Publication | Closed Access

Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy

NanomedicineIrinotecan Co-loaded LiposomesEngineeringMedicinePharmacologyTumor TargetingAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchBiomolecular Engineering